Pricing
Navire Pharma
Contact
No bio yet
Uma Sinha
Chief Scientific Officer, BridgeBio
Pedro J. Beltran
SVP & Head of Biology for Oncology
Carl Dambkowski
Head of Clinical Strategy
6 people, 0 jobs
This person is not in any offices
Navire Pharma is developing SHP2 inhibitors as effective additions to the therapeutic arsenal for difficult-to-treat cancers.
Industries
Headquarters
Employees
Links
Optima Partners
Brookhaven National Laboratory
Tremend Software Consulting
Ocular Therapeutix
SunDrive
View more